MRD Testing Collaborative

ALAN is a partner of MRD Testing Collaborative – a group dedicated to providing education on minimal residual disease testing in the blood cancer community


The mission and purpose of the MRD Testing Collaborative is to inform patients and health care professionals on personalized testing in the blood cancer community, with a focus on minimal residual disease (MRD). The Collaborative also brings together like-minded patient advocacy stakeholders and industry partners to collectively address blood cancer patient needs regarding testing.

For more information and resource center: